Lanreotide Acetate Injection
Product Images NDC 69097-906

Product Visual Gallery

This gallery contains 39 technical images submitted to the FDA as part of the official labeling for Lanreotide Acetate (NDC 69097-906). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Figure 1)

Progression-free survival probability over time is depicted in the given data. The graph shows the survival outcomes of patients receiving Lanreotide Injection compared to those on placebo over several months. The hazard ratio and statistical significance level are also provided for comparison between the two groups.*

FDA Label Image

Figure 10 (Figure 10)

FDA Label Image

Figure 11 (Figure 11)

FDA Label Image

Figure 12 (Figure 12)

FDA Label Image

Figure 13 (Figure 13)

FDA Label Image

Figure 14 (Figure 14)

FDA Label Image

Figure 15 (Figure 15)

FDA Label Image

Figure 16 (Figure 16)

FDA Label Image

Figure 17 (Figure 17)

FDA Label Image

Figure 18 (Figure 18)

FDA Label Image

Figure 19 (Figure 19)

FDA Label Image

Figure 2 (Figure 2)

FDA Label Image

Figure 20 (Figure 20)

FDA Label Image

Figure 21 (Figure 21)

FDA Label Image

Figure 22 (Figure 22)

FDA Label Image

Figure 23 (Figure 23)

FDA Label Image

Figure 24 (Figure 24)

FDA Label Image

Figure 25 (Figure 25)

FDA Label Image

Figure 26 (Figure 26)

FDA Label Image

Figure 3 (Figure 3)

FDA Label Image

Figure 4 (Figure 4)

FDA Label Image

Figure 5 (Figure 5)

FDA Label Image

Figure 6 (Figure 6)

FDA Label Image

Figure 7 (Figure 7)

FDA Label Image

Figure 8 (Figure 8)

FDA Label Image

Figure 9 (Figure 9)

FDA Label Image

Carton Label_120mg (Carton Label 120mg)

FDA Label Image

Carton Label_60mg (Carton Label 60mg)

FDA Label Image

Carton Label_90mg (Carton Label 90mg)

FDA Label Image

Pouch Label_120mg (Pouch Label 120mg)

FDA Label Image

Pouch Label_60mg (Pouch Label 60mg)

FDA Label Image

Pouch Label_90mg (Pouch Label 90mg)

FDA Label Image

Pouch Sticker Label_120mg (Pouch Sticker Label 120mg)

This text provides information about Lanreotide injection, with a concentration of 120 mg/0.5 mL, intended for single-use only. The medication is manufactured by Pharmathen International in Rodopi, Greece, and is distributed by Cipla USA, Inc. The instructions advise leaving the injection at room temperature for 30 minutes before administration and discarding any unused portion. Additionally, the packaging includes a coding area labeled "Lok Non Varnished/Bxp."*

FDA Label Image

Pouch Sticker Label_60mg (Pouch Sticker Label 60mg)

This text provides important information about Lanreotide injection in the dosage of 60 mg per 0.2 mL. The instructions state that it is for single use only, and any unused portion should be discarded. Before administration, the product should be left at room temperature for 30 minutes. The manufacturing information includes Pharmathen International, S.A. in Rodopi, Greece, and it is manufactured for Cipla USA, Inc. located in Warren, NJ. The text also includes a code labeled as 90325517 and mentions an area related to coding and expiration.*

FDA Label Image

Pouch Sticker Label_90mg (Pouch Sticker Label 90mg)

This is a description of Lanreotide Injection with a concentration of 90 mg/0.3 mL. It is for single use only, and any unused portion should be discarded. The product needs to be left at room temperature for 30 minutes before administration. It is manufactured by Pharmathen International, S.A. in Rodopi, Greece, and manufactured for Cipla USA, Inc. located in Warren, NJ. The lot number is provided for tracking and expiry information.*

FDA Label Image

Structure (Structure)

FDA Label Image

Syringe Label_120mg (Syringe Label 120mg)

This is information about Lanreotide injection, with a concentration of 120 mg per 0.5 mL. It is for single use only, and any unused portion should be discarded. The manufacturing company is Pharmathen International, S.A. in Rodopi, Greece. The product is manufactured for Cila USA inc. located at Independence Boulevard, Suite 300, Warren, NJ 07059. The text also includes sections for Lot number, Expiration date, and Non Varnished/Coding Area.*

FDA Label Image

Syringe Label_60mg (Syringe Label 60mg)

FDA Label Image

Syringe Label_90mg (Syringe Label 90mg)

This text contains information about Lanreotide Injection for single use only. It is manufactured by Phamathen International, S.A. The injection comes in a vial with 0.03 mL of solution and should be discarded if any portion is left unused. The address mentioned is 300 Independence Boulevard, 07059 Warren, NJ.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.